Paul Lammers, M.D., M.Sc., joined Mirna Therapeutics in November 2009 as its President, CEO, and Director of the Board, during which time period was able to secure approximately $150 million in both private and public financings for the Company. Prior to joining Mirna Therapeutics, Dr. Lammers served as President of Repros Therapeutics in The Woodlands, Texas, after having served for 6 years as the Chief Medical Officer for EMD Serono Inc., a Division of German pharmaceutical company, Merck KgA. He began his career with Dutch pharmaceutical company, Organon, spending 8 years in the commercial and clinical operations in Europe and the US. He also served 4 years as Senior Vice President of clinical and regulatory affairs at Zonagen in The Woodlands, TX. Dr. Lammers obtained his Medical and Masters of Science degrees from Radboud University in Nijmegen, The Netherlands, and moved with his family to the US in 1992.